logo
logo

Lav Leads $19M Series B Funding In Novlead Biotech

Lav Leads $19M Series B Funding In Novlead Biotech

11/18/21, 4:52 PM
Money raised
$19 million
Round Type
series b
Medical devices maker Novlead Biotech announced on Tuesday that it has garnered 120 million yuan ($19 million) in a Series B round of financing led by the biomedical-focussed venture capital firm Lilly Asia Ventures (LAV).

Company Info

Company
Novlead Biotech
Additional Info
诺令生物致力于世界领先的医疗创新技术和定制化解决方案的提供。一氧化氮吸入技术和抗微生物新疗,高分子和创新的NO气体传输系统。